NAFLD and risk of cardiovascular disease

被引：3
|
作者：
Leake I.
机构：
[1] Nature Reviews Gastroenterology & Hepatology,
来源：
Nature Reviews Gastroenterology & Hepatology | 2019年 / 16卷 / 12期
关键词：
D O I：
10.1038/s41575-019-0234-7
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：706 / 706
相关论文
共 50 条
  • [41] Dietary Fructose Reduction Improves Markers of Cardiovascular Disease Risk in Hispanic-American Adolescents with NAFLD
    Jin, Ran
    Welsh, Jean A.
    Ngoc-Anh Le
    Holzberg, Jeffrey
    Sharma, Puneet
    Martin, Diego R.
    Vos, Miriam B.
    [J]. NUTRIENTS, 2014, 6 (08) : 3187 - 3201
  • [42] Non-alcoholic fatty liver disease (NAFLD) and 10-year risk of cardiovascular diseases
    Motamed, Nima
    Rabiee, Behnam
    Poustchi, Hossein
    Dehestani, Babak
    Hemasi, Gholam Reza
    Khonsari, Mahmood Reza
    Maadi, Mansooreh
    Saeedian, Fatemeh Sima
    Zamani, Farhad
    [J]. CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2017, 41 (01) : 31 - 38
  • [43] Cardiovascular and Systemic Risk in Nonalcoholic Fatty Liver Disease - Atherosclerosis as a Major Player in the Natural Course of NAFLD
    Lonardo, Amedeo
    Sookoian, Silvia
    Chonchol, Michel
    Loria, Paola
    Targher, Giovanni
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (29) : 5177 - 5192
  • [44] NAFLD PREVALENCE AND CARDIOVASCULAR RISK IN A POPULATION OF ADOLESCENTS IN SOUTHERN ITALY
    Caserta, C. A.
    Pendino, G. M.
    Surace, P.
    Fiorillo, M. T.
    Alicante, S.
    Vacalebre, C.
    Amato, F.
    Amante, A.
    Marra, M.
    Gutamo, G.
    Messineo, A.
    Surace, M.
    Polito, I.
    Cotichini, R.
    Ferrigno, L.
    Rosmini, F.
    Mele, A.
    Marcucci, F.
    [J]. JOURNAL OF HEPATOLOGY, 2009, 50 : S357 - S358
  • [45] The Relationship Between Type 2 Diabetes, NAFLD, and Cardiovascular Risk
    Cyrielle Caussy
    Adrien Aubin
    Rohit Loomba
    [J]. Current Diabetes Reports, 2021, 21
  • [46] NAFLD and Cardiovascular Risk: Direct Evidence for the Tale of Two Ages
    Lonardo, Amedeo
    Loria, Paola
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 (07): : 1851 - 1852
  • [47] The Relationship Between Type 2 Diabetes, NAFLD, and Cardiovascular Risk
    Caussy, Cyrielle
    Aubin, Adrien
    Loomba, Rohit
    [J]. CURRENT DIABETES REPORTS, 2021, 21 (05)
  • [48] Metabolic NAFLD subtypes align with cardiovascular and genetic risk factors
    Martinez-Arranz, Ibon
    Bruzzone, Chiara
    Noureddin, Mazen
    Gil-Redondo, Ruben
    Arretxe, Enara
    Iruarrizaga-Lejarreta, Marta
    Bizkarguenaga, Maider
    Minchole, Itziar
    Fernandez Ramos, David
    Lopitz Otsoa, Fernando
    Mayo, Rebeca
    Embade, Nieves
    Newberry, Elizabeth
    Mittendorf, Bettina
    Izquierdo-Sanchez, Laura
    Perez Castano, Ylenia
    Smid, Vaclav
    Arnold, Jorge
    Krawczyk, Marcin
    Iruzubieta, Paula
    Marigorta, Urko M.
    Morrison, Martine C.
    Kleemann, Robert
    Duce, Antonio Martin
    Hayardeny, Liat
    Vitek, Libor
    Bruha, Radan
    Aller, Rocio
    Crespo, Javier
    Romero Gomez, Manuel
    Maria Banales, Jesus
    Arrese, Marco
    Cusi, Kenneth
    Bugianesi, Elisabetta
    Klein, Samuel
    Lu, Shelly C.
    Anstee, Quentin
    Millet, Oscar
    Davidson, Nicholas O.
    Alonso, Cristina
    Mato, Jose M.
    [J]. JOURNAL OF HEPATOLOGY, 2022, 77 : S671 - S672
  • [49] Noninvasive tool for the diagnosis of NAFLD in association with atherosclerotic cardiovascular risk
    Musa N.I.
    Safwat E.
    Abdelhakam S.M.
    Farid A.M.
    Hetta W.M.
    [J]. Egyptian Liver Journal, 9 (1)
  • [50] Glucocorticosteroids and the Risk of NAFLD in Inflammatory Bowel Disease
    Jarmakiewicz-Czaja, Sara
    Sokal, Aneta
    Pardak, Piotr
    Filip, Rafal
    [J]. CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 2022
12345